Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Insights and Forecast to 2031

Report ID: 1564157 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Product Introduction
    1.2 Market by Type
        1.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Barium-based Contrast Media
        1.2.3 Iodinated Contrast Media
        1.2.4 Gadolinium-based Contrast Media
        1.2.5 Microbubble Contrast Media
    1.3 Market by Application
        1.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Radiology
        1.3.3 Interventional Radiology
        1.3.4 Interventional Cardiology
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Estimates and Forecasts 2017-2028
    2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Estimates and Forecasts 2017-2028
    2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region
        2.4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2017-2022)
        2.4.2 Global Sales Contrast Agents for Magnetic Resonance Imaging (MRI) by Region (2023-2028)
    2.5 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region
        2.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2017-2022)
        2.5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers
        3.1.1 Global Top Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers by Sales (2017-2022)
        3.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) in 2021
    3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers
        3.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (2017-2022)
        3.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue in 2021
    3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type
        4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Historical Sales by Type (2017-2022)
        4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecasted Sales by Type (2023-2028)
        4.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    4.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type
        4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Historical Revenue by Type (2017-2022)
        4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    4.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type
        4.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2017-2022)
        4.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application
        5.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Historical Sales by Application (2017-2022)
        5.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecasted Sales by Application (2023-2028)
        5.1.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application
        5.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Historical Revenue by Application (2017-2022)
        5.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application
        5.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2017-2022)
        5.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
        6.1.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2028)
        6.1.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2028)
    6.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
        6.2.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2028)
        6.2.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2028)
    6.3 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        6.3.1 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2028)
        6.3.2 North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
        7.1.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2028)
        7.1.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2028)
    7.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
        7.2.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2028)
        7.2.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2028)
    7.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        7.3.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2028)
        7.3.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
        8.1.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2028)
        8.1.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2028)
    8.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
        8.2.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2028)
        8.2.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2028)
    8.3 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Region
        8.3.1 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2017-2028)
        8.3.2 Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
        9.1.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2028)
        9.1.2 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2028)
    9.2 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
        9.2.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2028)
        9.2.2 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2028)
    9.3 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        9.3.1 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2028)
        9.3.2 Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Type
        10.1.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2028)
    10.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Application
        10.2.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2028)
    10.3 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country
        10.3.1 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 GE Healthcare (US)
        11.1.1 GE Healthcare (US) Corporation Information
        11.1.2 GE Healthcare (US) Overview
        11.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 GE Healthcare (US) Recent Developments
    11.2 Bracco Imaging (Italy)
        11.2.1 Bracco Imaging (Italy) Corporation Information
        11.2.2 Bracco Imaging (Italy) Overview
        11.2.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bracco Imaging (Italy) Recent Developments
    11.3 Bayer HealthCare (Germany)
        11.3.1 Bayer HealthCare (Germany) Corporation Information
        11.3.2 Bayer HealthCare (Germany) Overview
        11.3.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bayer HealthCare (Germany) Recent Developments
    11.4 Guerbet (France)
        11.4.1 Guerbet (France) Corporation Information
        11.4.2 Guerbet (France) Overview
        11.4.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Guerbet (France) Recent Developments
    11.5 Lantheus (US)
        11.5.1 Lantheus (US) Corporation Information
        11.5.2 Lantheus (US) Overview
        11.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Lantheus (US) Recent Developments
    11.6 Daiichi Sankyo (Japan)
        11.6.1 Daiichi Sankyo (Japan) Corporation Information
        11.6.2 Daiichi Sankyo (Japan) Overview
        11.6.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Daiichi Sankyo (Japan) Recent Developments
    11.7 Unijules Life Sciences (India)
        11.7.1 Unijules Life Sciences (India) Corporation Information
        11.7.2 Unijules Life Sciences (India) Overview
        11.7.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Unijules Life Sciences (India) Recent Developments
    11.8 J.B. Chemicals and Pharmaceuticals (India)
        11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
        11.8.2 J.B. Chemicals and Pharmaceuticals (India) Overview
        11.8.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
    11.9 Spago Nanomedicine (Sweden)
        11.9.1 Spago Nanomedicine (Sweden) Corporation Information
        11.9.2 Spago Nanomedicine (Sweden) Overview
        11.9.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Spago Nanomedicine (Sweden) Recent Developments
    11.10 Taejoon Pharm (South Korea)
        11.10.1 Taejoon Pharm (South Korea) Corporation Information
        11.10.2 Taejoon Pharm (South Korea) Overview
        11.10.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Taejoon Pharm (South Korea) Recent Developments
    11.11 Jodas (India)
        11.11.1 Jodas (India) Corporation Information
        11.11.2 Jodas (India) Overview
        11.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Jodas (India) Recent Developments
    11.12 Magnus Health (India)
        11.12.1 Magnus Health (India) Corporation Information
        11.12.2 Magnus Health (India) Overview
        11.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Magnus Health (India) Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Chain Analysis
    12.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Production Mode & Process
    12.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales and Marketing
        12.4.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Channels
        12.4.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors
    12.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Trends
    13.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Drivers
    13.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Challenges
    13.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Market Restraints
14 Key Findings in The Global Contrast Agents for Magnetic Resonance Imaging (MRI) Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Barium-based Contrast Media
    Table 3. Major Manufacturers of Iodinated Contrast Media
    Table 4. Major Manufacturers of Gadolinium-based Contrast Media
    Table 5. Major Manufacturers of Microbubble Contrast Media
    Table 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2017-2022) & (K Pcs)
    Table 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2017-2022)
    Table 10. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2023-2028) & (K Pcs)
    Table 11. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2023-2028)
    Table 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2017-2022)
    Table 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2023-2028)
    Table 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Manufacturers (2017-2022) & (K Pcs)
    Table 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Manufacturers (2017-2022)
    Table 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Manufacturers (2017-2022)
    Table 20. Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Manufacturers (2017-2022) &(USD/Pcs)
    Table 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contrast Agents for Magnetic Resonance Imaging (MRI) as of 2021)
    Table 23. Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered
    Table 25. Date of Manufacturers Enter into Contrast Agents for Magnetic Resonance Imaging (MRI) Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)
    Table 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2023-2028) & (K Pcs)
    Table 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Type (2017-2022)
    Table 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Type (2023-2028)
    Table 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Type (2017-2022)
    Table 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Type (2023-2028)
    Table 35. Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Type (2017-2022) & (USD/Pcs)
    Table 36. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by Type (2023-2028) & (USD/Pcs)
    Table 37. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)
    Table 38. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2023-2028) & (K Pcs)
    Table 39. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Application (2017-2022)
    Table 40. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Application (2023-2028)
    Table 41. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Application (2017-2022)
    Table 44. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Application (2023-2028)
    Table 45. Contrast Agents for Magnetic Resonance Imaging (MRI) Price by Application (2017-2022) & (USD/Pcs)
    Table 46. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Price Forecast by Application (2023-2028) & (USD/Pcs)
    Table 47. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)
    Table 48. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2023-2028) & (K Pcs)
    Table 49. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)
    Table 52. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2023-2028) & (K Pcs)
    Table 53. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)
    Table 56. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2023-2028) & (K Pcs)
    Table 57. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)
    Table 60. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2023-2028) & (K Pcs)
    Table 61. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)
    Table 64. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2023-2028) & (K Pcs)
    Table 65. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)
    Table 68. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2023-2028) & (K Pcs)
    Table 69. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)
    Table 72. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2023-2028) & (K Pcs)
    Table 73. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)
    Table 76. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2023-2028) & (K Pcs)
    Table 77. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2017-2022) & (K Pcs)
    Table 80. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2023-2028) & (K Pcs)
    Table 81. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)
    Table 84. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2023-2028) & (K Pcs)
    Table 85. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)
    Table 88. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2023-2028) & (K Pcs)
    Table 89. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)
    Table 92. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2023-2028) & (K Pcs)
    Table 93. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)
    Table 96. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2023-2028) & (K Pcs)
    Table 97. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)
    Table 100. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2023-2028) & (K Pcs)
    Table 101. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)
    Table 104. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2023-2028) & (K Pcs)
    Table 105. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2023-2028) & (US$ Million)
    Table 107. GE Healthcare (US) Corporation Information
    Table 108. GE Healthcare (US) Description and Major Businesses
    Table 109. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 110. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. GE Healthcare (US) Recent Developments
    Table 112. Bracco Imaging (Italy) Corporation Information
    Table 113. Bracco Imaging (Italy) Description and Major Businesses
    Table 114. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 115. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Bracco Imaging (Italy) Recent Developments
    Table 117. Bayer HealthCare (Germany) Corporation Information
    Table 118. Bayer HealthCare (Germany) Description and Major Businesses
    Table 119. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 120. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Bayer HealthCare (Germany) Recent Developments
    Table 122. Guerbet (France) Corporation Information
    Table 123. Guerbet (France) Description and Major Businesses
    Table 124. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 125. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Guerbet (France) Recent Developments
    Table 127. Lantheus (US) Corporation Information
    Table 128. Lantheus (US) Description and Major Businesses
    Table 129. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 130. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Lantheus (US) Recent Developments
    Table 132. Daiichi Sankyo (Japan) Corporation Information
    Table 133. Daiichi Sankyo (Japan) Description and Major Businesses
    Table 134. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 135. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Daiichi Sankyo (Japan) Recent Developments
    Table 137. Unijules Life Sciences (India) Corporation Information
    Table 138. Unijules Life Sciences (India) Description and Major Businesses
    Table 139. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 140. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Unijules Life Sciences (India) Recent Developments
    Table 142. J.B. Chemicals and Pharmaceuticals (India) Corporation Information
    Table 143. J.B. Chemicals and Pharmaceuticals (India) Description and Major Businesses
    Table 144. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 145. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. J.B. Chemicals and Pharmaceuticals (India) Recent Developments
    Table 147. Spago Nanomedicine (Sweden) Corporation Information
    Table 148. Spago Nanomedicine (Sweden) Description and Major Businesses
    Table 149. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 150. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Spago Nanomedicine (Sweden) Recent Developments
    Table 152. Taejoon Pharm (South Korea) Corporation Information
    Table 153. Taejoon Pharm (South Korea) Description and Major Businesses
    Table 154. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 155. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Taejoon Pharm (South Korea) Recent Developments
    Table 157. Jodas (India) Corporation Information
    Table 158. Jodas (India) Description and Major Businesses
    Table 159. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 160. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Jodas (India) Recent Developments
    Table 162. Magnus Health (India) Corporation Information
    Table 163. Magnus Health (India) Description and Major Businesses
    Table 164. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 165. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Magnus Health (India) Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List
    Table 170. Contrast Agents for Magnetic Resonance Imaging (MRI) Customers List
    Table 171. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Trends
    Table 172. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Drivers
    Table 173. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Challenges
    Table 174. Contrast Agents for Magnetic Resonance Imaging (MRI) Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Product Picture
    Figure 3. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Type in 2021 & 2028
    Figure 3. Barium-based Contrast Media Product Picture
    Figure 4. Iodinated Contrast Media Product Picture
    Figure 5. Gadolinium-based Contrast Media Product Picture
    Figure 6. Microbubble Contrast Media Product Picture
    Figure 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Application in 2021 & 2028
    Figure 8. Radiology
    Figure 9. Interventional Radiology
    Figure 10. Interventional Cardiology
    Figure 11. Contrast Agents for Magnetic Resonance Imaging (MRI) Report Years Considered
    Figure 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2017-2028 (K Pcs)
    Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2017-2028 (US$ Million)
    Figure 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2017-2022)
    Figure 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2023-2028)
    Figure 18. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2017-2028) & (K Pcs)
    Figure 19. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2017-2028) & (K Pcs)
    Figure 21. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2017-2028) & (K Pcs)
    Figure 23. Asia-Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2017-2028) & (K Pcs)
    Figure 25. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales YoY (2017-2028) & (K Pcs)
    Figure 27. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Contrast Agents for Magnetic Resonance Imaging (MRI) in the World: Market Share by Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue in 2021
    Figure 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    Figure 32. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    Figure 33. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    Figure 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    Figure 35. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    Figure 36. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    Figure 37. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    Figure 38. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    Figure 39. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Country (2017-2028)
    Figure 40. North America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country (2017-2028)
    Figure 41. U.S. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    Figure 44. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    Figure 46. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Country (2017-2028)
    Figure 48. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country (2017-2028)
    Figure 49. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 50. France Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Region (2017-2028)
    Figure 60. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 63. India Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Country (2017-2028)
    Figure 75. Latin America Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country (2017-2028)
    Figure 76. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Share by Country (2017-2028)
    Figure 85. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue (2017-2028) & (US$ Million)
    Figure 88. Contrast Agents for Magnetic Resonance Imaging (MRI) Value Chain
    Figure 89. Contrast Agents for Magnetic Resonance Imaging (MRI) Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
Frequently Asked Questions
Contrast Agents for Magnetic Resonance Imaging (MRI) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Contrast Agents for Magnetic Resonance Imaging (MRI) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Contrast Agents for Magnetic Resonance Imaging (MRI) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports